Cargando…
Endoscopic Ultrasound-Guided Gastrojejunostomy for Malignant Afferent Loop Syndrome Using a Fully Covered Metal Stent: A Multicenter Experience
Background: Endoscopic-ultrasound-guided gastrojejunostomy (EUS-GJ) can be a new alternative for patients with malignant afferent loop syndrome (MALS). However, a fully covered self-expandable metal stent (FCSEMS) has not been well investigated in this setting. Methods: This is a multicenter retrosp...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10219552/ https://www.ncbi.nlm.nih.gov/pubmed/37240629 http://dx.doi.org/10.3390/jcm12103524 |
_version_ | 1785049036921765888 |
---|---|
author | Matsubara, Saburo Takahashi, Sho Takahara, Naminatsu Nakagawa, Keito Suda, Kentaro Otsuka, Takeshi Nakai, Yousuke Isayama, Hiroyuki Oka, Masashi Nagoshi, Sumiko |
author_facet | Matsubara, Saburo Takahashi, Sho Takahara, Naminatsu Nakagawa, Keito Suda, Kentaro Otsuka, Takeshi Nakai, Yousuke Isayama, Hiroyuki Oka, Masashi Nagoshi, Sumiko |
author_sort | Matsubara, Saburo |
collection | PubMed |
description | Background: Endoscopic-ultrasound-guided gastrojejunostomy (EUS-GJ) can be a new alternative for patients with malignant afferent loop syndrome (MALS). However, a fully covered self-expandable metal stent (FCSEMS) has not been well investigated in this setting. Methods: This is a multicenter retrospective cohort study. Consecutive patients that underwent EUS-GJ using a FCSEMS for MALS between April 2017 and November 2022 were enrolled. Primary outcomes were technical and clinical success rates. Secondary outcomes were adverse events, recurrent symptoms, and overall survival. Results: Twelve patients (median age: 67.5 years (interquartile range: 58–74.8); 50% male) were included. The most common primary disease and type of previous surgery were pancreatic cancer (67%) and pancreatoduodenectomy (75%), respectively. Technical success and clinical success were achieved in all patients. Procedure-related adverse events occurred in one patient (8%) with mild peritonitis. During a median follow-up of 96.5 days, one patient (8%) had recurrent symptoms due to the EUS-GJ stent dysfunction; including biliary events unrelated to the EUS-GJ stent, five patients (42%) had recurrent events. The median overall survival was 137 days. Nine patients (75%) died due to disease progression. Conclusions: EUS-GJ with a FCSEMS seems safe and effective for MALS with high technical and clinical success rates and an acceptable recurrence rate. |
format | Online Article Text |
id | pubmed-10219552 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-102195522023-05-27 Endoscopic Ultrasound-Guided Gastrojejunostomy for Malignant Afferent Loop Syndrome Using a Fully Covered Metal Stent: A Multicenter Experience Matsubara, Saburo Takahashi, Sho Takahara, Naminatsu Nakagawa, Keito Suda, Kentaro Otsuka, Takeshi Nakai, Yousuke Isayama, Hiroyuki Oka, Masashi Nagoshi, Sumiko J Clin Med Article Background: Endoscopic-ultrasound-guided gastrojejunostomy (EUS-GJ) can be a new alternative for patients with malignant afferent loop syndrome (MALS). However, a fully covered self-expandable metal stent (FCSEMS) has not been well investigated in this setting. Methods: This is a multicenter retrospective cohort study. Consecutive patients that underwent EUS-GJ using a FCSEMS for MALS between April 2017 and November 2022 were enrolled. Primary outcomes were technical and clinical success rates. Secondary outcomes were adverse events, recurrent symptoms, and overall survival. Results: Twelve patients (median age: 67.5 years (interquartile range: 58–74.8); 50% male) were included. The most common primary disease and type of previous surgery were pancreatic cancer (67%) and pancreatoduodenectomy (75%), respectively. Technical success and clinical success were achieved in all patients. Procedure-related adverse events occurred in one patient (8%) with mild peritonitis. During a median follow-up of 96.5 days, one patient (8%) had recurrent symptoms due to the EUS-GJ stent dysfunction; including biliary events unrelated to the EUS-GJ stent, five patients (42%) had recurrent events. The median overall survival was 137 days. Nine patients (75%) died due to disease progression. Conclusions: EUS-GJ with a FCSEMS seems safe and effective for MALS with high technical and clinical success rates and an acceptable recurrence rate. MDPI 2023-05-17 /pmc/articles/PMC10219552/ /pubmed/37240629 http://dx.doi.org/10.3390/jcm12103524 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Matsubara, Saburo Takahashi, Sho Takahara, Naminatsu Nakagawa, Keito Suda, Kentaro Otsuka, Takeshi Nakai, Yousuke Isayama, Hiroyuki Oka, Masashi Nagoshi, Sumiko Endoscopic Ultrasound-Guided Gastrojejunostomy for Malignant Afferent Loop Syndrome Using a Fully Covered Metal Stent: A Multicenter Experience |
title | Endoscopic Ultrasound-Guided Gastrojejunostomy for Malignant Afferent Loop Syndrome Using a Fully Covered Metal Stent: A Multicenter Experience |
title_full | Endoscopic Ultrasound-Guided Gastrojejunostomy for Malignant Afferent Loop Syndrome Using a Fully Covered Metal Stent: A Multicenter Experience |
title_fullStr | Endoscopic Ultrasound-Guided Gastrojejunostomy for Malignant Afferent Loop Syndrome Using a Fully Covered Metal Stent: A Multicenter Experience |
title_full_unstemmed | Endoscopic Ultrasound-Guided Gastrojejunostomy for Malignant Afferent Loop Syndrome Using a Fully Covered Metal Stent: A Multicenter Experience |
title_short | Endoscopic Ultrasound-Guided Gastrojejunostomy for Malignant Afferent Loop Syndrome Using a Fully Covered Metal Stent: A Multicenter Experience |
title_sort | endoscopic ultrasound-guided gastrojejunostomy for malignant afferent loop syndrome using a fully covered metal stent: a multicenter experience |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10219552/ https://www.ncbi.nlm.nih.gov/pubmed/37240629 http://dx.doi.org/10.3390/jcm12103524 |
work_keys_str_mv | AT matsubarasaburo endoscopicultrasoundguidedgastrojejunostomyformalignantafferentloopsyndromeusingafullycoveredmetalstentamulticenterexperience AT takahashisho endoscopicultrasoundguidedgastrojejunostomyformalignantafferentloopsyndromeusingafullycoveredmetalstentamulticenterexperience AT takaharanaminatsu endoscopicultrasoundguidedgastrojejunostomyformalignantafferentloopsyndromeusingafullycoveredmetalstentamulticenterexperience AT nakagawakeito endoscopicultrasoundguidedgastrojejunostomyformalignantafferentloopsyndromeusingafullycoveredmetalstentamulticenterexperience AT sudakentaro endoscopicultrasoundguidedgastrojejunostomyformalignantafferentloopsyndromeusingafullycoveredmetalstentamulticenterexperience AT otsukatakeshi endoscopicultrasoundguidedgastrojejunostomyformalignantafferentloopsyndromeusingafullycoveredmetalstentamulticenterexperience AT nakaiyousuke endoscopicultrasoundguidedgastrojejunostomyformalignantafferentloopsyndromeusingafullycoveredmetalstentamulticenterexperience AT isayamahiroyuki endoscopicultrasoundguidedgastrojejunostomyformalignantafferentloopsyndromeusingafullycoveredmetalstentamulticenterexperience AT okamasashi endoscopicultrasoundguidedgastrojejunostomyformalignantafferentloopsyndromeusingafullycoveredmetalstentamulticenterexperience AT nagoshisumiko endoscopicultrasoundguidedgastrojejunostomyformalignantafferentloopsyndromeusingafullycoveredmetalstentamulticenterexperience |